These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29150164)

  • 21. Effectiveness of testosterone replacement in men with obesity: a systematic review and meta-analysis.
    Mangolim AS; Brito LAR; Nunes-Nogueira VDS
    Eur J Endocrinol; 2021 Dec; 186(1):123-135. PubMed ID: 34738915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testosterone therapy of men with type 2 diabetes mellitus - a randomized, double-blinded, placebo-controlled study.
    Magnussen LV
    Dan Med J; 2017 Jul; 64(7):. PubMed ID: 28673384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of testosterone replacement therapy withdrawal and re-treatment in hypogonadal elderly men upon obesity, voiding function and prostate safety parameters.
    Yassin A; Nettleship JE; Talib RA; Almehmadi Y; Doros G
    Aging Male; 2016; 19(1):64-9. PubMed ID: 26742589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What are the benefits and harms of testosterone therapy for male sexual dysfunction?-a systematic review.
    Dimitropoulos K; Verze P; Van den Broeck T; Salonia A; Yuan CY; Hatzimouratidis K; Dohle G
    Int J Impot Res; 2019 Nov; 31(6):380-391. PubMed ID: 30918363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between simultaneous PSA and serum testosterone concentrations among eugonadal, untreated hypogonadal and hypogonadal men receiving testosterone replacement therapy.
    Grober ED; Lamb DJ; Khera M; Murthy L; Lipshultz LI
    Int J Impot Res; 2008; 20(6):561-5. PubMed ID: 18843272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of testosterone therapy in obese men with low testosterone levels, for losing weight, controlling obesity complications, and preventing cardiovascular events: Protocol of a systematic review of randomized controlled trials.
    Mangolim AS; Brito LAR; Nunes-Nogueira VS
    Medicine (Baltimore); 2018 Apr; 97(17):e0482. PubMed ID: 29703008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular safety of testosterone replacement therapy in men: an updated systematic review and meta-analysis.
    Corona G; Rastrelli G; Sparano C; Carinci V; Casella G; Vignozzi L; Sforza A; Maggi M
    Expert Opin Drug Saf; 2024 May; 23(5):565-579. PubMed ID: 38553429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes.
    Muraleedharan V; Marsh H; Kapoor D; Channer KS; Jones TH
    Eur J Endocrinol; 2013 Dec; 169(6):725-33. PubMed ID: 23999642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testosterone Replacement Therapy and Mortality in Older Men.
    Hackett GI
    Drug Saf; 2016 Feb; 39(2):117-30. PubMed ID: 26482385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testosterone replacement therapy following radical prostatectomy.
    Khera M; Grober ED; Najari B; Colen JS; Mohamed O; Lamb DJ; Lipshultz LI
    J Sex Med; 2009 Apr; 6(4):1165-1170. PubMed ID: 19207277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testosterone therapy and risk of myocardial infarction: a pharmacoepidemiologic study.
    Etminan M; Skeldon SC; Goldenberg SL; Carleton B; Brophy JM
    Pharmacotherapy; 2015 Jan; 35(1):72-8. PubMed ID: 25582846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controversies regarding the cardiovascular effects of testosterone replacement therapy in older men.
    Chrysant SG
    Drugs Today (Barc); 2018 Jan; 54(1):25-34. PubMed ID: 29569659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle-aged and elderly men.
    Yassin A; Almehmadi Y; Saad F; Doros G; Gooren L
    Clin Endocrinol (Oxf); 2016 Jan; 84(1):107-14. PubMed ID: 26331709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testosterone replacement therapy (TRT) and prostate cancer: An updated systematic review with a focus on previous or active localized prostate cancer.
    Lenfant L; Leon P; Cancel-Tassin G; Audouin M; Staerman F; Rouprêt M; Cussenot O
    Urol Oncol; 2020 Aug; 38(8):661-670. PubMed ID: 32409202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. State-of-the-Art: a Review of Cardiovascular Effects of Testosterone Replacement Therapy in Adult Males.
    Elsherbiny A; Tricomi M; Bhatt D; Dandapantula HK
    Curr Cardiol Rep; 2017 Apr; 19(4):35. PubMed ID: 28361372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study.
    Wallis CJ; Lo K; Lee Y; Krakowsky Y; Garbens A; Satkunasivam R; Herschorn S; Kodama RT; Cheung P; Narod SA; Nam RK
    Lancet Diabetes Endocrinol; 2016 Jun; 4(6):498-506. PubMed ID: 27165609
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.